Basic & Clinical Medicine ›› 2018, Vol. 38 ›› Issue (4): 475-479.

Previous Articles     Next Articles

siRNA-mediated antizyme inhibitor down-regulates the expression of ornithine decarboxylase of prostate cancer cell PC3

  

  • Received:2017-03-20 Revised:2017-05-26 Online:2018-04-05 Published:2018-03-27

Abstract: Objective To evaluate whether down-regulating antizyme inhibitor(AZIN) can regulate the expression of ornithine decarboxylase(ODC) and the proliferation of prostate cancer cell PC3 or not. Methods siRNA-AZIN transfected prostate cancer cell PC3, the level of antizyme(AZ), AZIN and ODC were measured by RT-PCR and westernblot. MTT was used to measure the proliferation of cells. Results The mRNA level of AZIN declined(P<0.01); the protein level of AZIN and ODC declined(P<0.05). Knockdown of AZIN significantly inhibited the proliferation of PC3(P<0.05). Conclusions Transfecting siRNA-AZIN can decrease the level of AZIN, then the decline level of ODC inhibits the proliferation of PC3.

Key words: antizyme inhibitor, ornithine decarboxylase, antizyme, siRNA

CLC Number: